X
FDA backs Astellas/Seattle Genetics bladder cancer drug
https://pharmaphorum.com/news/fda-backs-astellas-seattle-genetics-bladder-cancer-drug/
Seattle Genetics
Seattle Genetics and Astellas gain Breakthrough Designation for urothelial cancer treatment
The FDA has granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug conjugate (ADC) being developed by Seattle Genetics and Astellas.
1 2